Mangiferin: An effective agent against human malignancies

Author:

Irshad Nimra1,Naeem Hammad12,Shahbaz Muhammad1,Imran Muhammad3,Mujtaba Ahmed4,Hussain Muzzamal5ORCID,Al Abdulmonem Waleed6,Alsagaby Suliman A.7,Yehuala Tadesse Fenta8ORCID,Abdelgawad Mohamed A.9,Ghoneim Mohammed M.10,Mostafa Ehab M.1112,Selim Samy13ORCID,Al Jaouni Soad K.14

Affiliation:

1. Department of Food Science and Technology Muhammad Nawaz Shareef University of Agriculture, Multan Multan Pakistan

2. Post‐Harvest Research Centre Ayub Agricultural Research Institute, Faisalabad Faisalabad Pakistan

3. Department of Food Science and Technology University of Narowal Narowal Pakistan

4. Department of Food Sciences and Technology, Faculty of Engineering Sciences and Technology Hamdard University Islamabad Campus Islamabad Pakistan

5. Department of Food Sciences Government College University Faisalabad Faisalabad Pakistan

6. Department of Pathology, College of Medicine Qassim University Buraidah Saudi Arabia

7. Department of Medical Laboratory Sciences, College of Applied Medical Sciences Majmaah University AL‐Majmaah Saudi Arabia

8. Faculty of Chemical and Food Engineering, Bahir Dar Institute of Technology Bahir Dar University Bahir dar Ethiopia

9. Department of Pharmaceutical Chemistry, College of Pharmacy Jouf University Sakaka Aljouf Saudi Arabia

10. Department of Pharmacy Practice, College of Pharmacy AlMaarefa University Ad Diriyah Riyadh Saudi Arabia

11. Department of Pharmacognosy, College of Pharmacy Jouf University Sakaka Saudi Arabia

12. Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys) Al‐Azhar University Cairo Egypt

13. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences Jouf University Sakaka Saudi Arabia

14. Department of Hematology/Oncology, Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine King Abdulaziz University Jeddah Saudi Arabia

Abstract

AbstractMangiferin is a bioactive substance present in high concentration in mangoes and also in some other fruits. Owing to its potential as a chemopreventive and chemotherapeutic agent against several types of cancer, this unique, significant, and well‐researched polyphenol has received a lot of attention recently. It possesses the ability to treat cancers, including rectal cancer, prostate cancer, ovarian cancer, leukemia, gastric cancer, liver cancer, chronic pancreatitis, and lung cancer. It can control/regulate multiple key signaling pathways, such as signal transducer and activator of transcription 3 (STAT3), second mitochondria‐derived activator of caspases/direct inhibitor of apoptosis (IAP)‐binding protein with low propidium iodide (pl) (Smac/DIABLO) nuclear factor kappa B (NF‐κB), phosphatidylinositol 3 kinase/protein 3 kinase (PI3K/Akt), transforming growth factor beta/suppressor of mothers against decapentaplegic (TGF‐β/SMAD), c‐jun N‐terminal kinase/p38 mitogen‐activated protein kinase (JNK/p38‐MAPK), and phosphor‐I kappa B kinase (p‐IκB), which are crucial to the development of cancers. By triggering apoptotic signals and halting the advancement of the cell cycle, it can also prevent some cancer cell types from proliferating and developing. It has been revealed that mangiferin targets a variety of adhesion molecules, cytokines, pro‐inflammatory transcription factors, kinases, chemokines, growth factors, and cell‐cycle proteins. By means of preventing the onset, advancement, and metastasis of cancer, these targets may mediate the chemopreventive and therapeutic effects of mangiferin. Mangiferin has confirmed potential benefits in lung, cervical, breast, brain, and prostate cancers as well as leukemia whether administered alone or in combination with recognized anticancer compounds. More clinical trials and research investigations are required to completely unleash the potential of mangiferin, which may lower the risk of cancer onset and act as a preventive and therapeutic alternative for a number of cancers.

Publisher

Wiley

Reference89 articles.

1. Colon cancer: A clinician's perspective in 2019;Ahmed M.;Gastroenterology Research,2020

2. Renoprotective effects of mangiferin: Pharmacological advances and future perspectives;Akter S.;International Journal of Environmental Research and Public Health,2022

3. Phospholipid‐based topical nano‐hydrogel of Mangiferin: Enhanced topical delivery and improved dermatokinetics;Alkholifi F. K.;Gels,2023

4. Challenges in liver cancer and possible treatment approaches;Anwanwan D.;Biochimica et Biophysica Acta (BBA) – Reviews on Cancer,2020

5. AGA clinical practice update on pancreas cancer screening in high‐risk individuals: Expert review;Aslanian H. R.;Gastroenterology,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3